72 related articles for article (PubMed ID: 17329481)
41. Second-generation antipsychotics and pregnancy complications: the impact of confounding by indication.
Oshagbemi OA; Daniel A; Yunusa I
Eur J Clin Pharmacol; 2021 Mar; 77(3):439-440. PubMed ID: 33079218
[No Abstract] [Full Text] [Related]
42. Association between antipsychotic agents and risk of lung cancer: a nested case-control study.
Li J; Tang F; Si S; Xue F
Cancer Commun (Lond); 2022 Feb; 42(2):175-178. PubMed ID: 34984858
[No Abstract] [Full Text] [Related]
43. Suspended judgment. Significance tests of covariate imbalance in clinical trials.
Begg CB
Control Clin Trials; 1990 Aug; 11(4):223-5. PubMed ID: 2171874
[No Abstract] [Full Text] [Related]
44. Confounding by indication of a specific antipsychotic and the increase of body mass index among children and adolescents.
Martínez-Ortega JM; Diaz-Atienza F; Gutiérrez-Rojas L; Jurado D; Gurpegui M
Eur Child Adolesc Psychiatry; 2011 Dec; 20(11-12):597-8. PubMed ID: 21927910
[No Abstract] [Full Text] [Related]
45. Severe hyperlipidemia associated with olanzapine and quetiapine use.
Carnahan RM; Reantaso AA; Teegarden BA; Pogue T
Am J Psychiatry; 2007 Oct; 164(10):1614-5. PubMed ID: 17898359
[No Abstract] [Full Text] [Related]
46. Exploring genetic variations that may be associated with the direct effects of some antipsychotics on lipid levels.
de Leon J; Correa JC; Ruaño G; Windemuth A; Arranz MJ; Diaz FJ
Schizophr Res; 2008 Jan; 98(1-3):40-6. PubMed ID: 18031993
[TBL] [Abstract][Full Text] [Related]
47. Hyperlipidemia following treatment with antipsychotic medications.
Olfson M; Marcus SC; Corey-Lisle P; Tuomari AV; Hines P; L'Italien GJ
Am J Psychiatry; 2006 Oct; 163(10):1821-5. PubMed ID: 17012695
[TBL] [Abstract][Full Text] [Related]
48. [Efficacy of atypical antipsychotics in patients with Alzheimer's dementia. CATIE-AD-Study (Clinical Antipsychotic Trials of Intervention Effectiveness Alzheimer's Disease)].
Förstl H
Internist (Berl); 2007 Jun; 48(6):642-4. PubMed ID: 17497111
[No Abstract] [Full Text] [Related]
49. Confounding by indication and the risk of hyperlipidemia in observational studies of antipsychotics.
Rico-Villademoros F; Calandre EP
Am J Psychiatry; 2007 Mar; 164(3):525-6; author reply 526. PubMed ID: 17329481
[No Abstract] [Full Text] [Related]
50. Dyslipidemia and atypical antipsychotic drugs.
Casey DE
J Clin Psychiatry; 2004; 65 Suppl 18():27-35. PubMed ID: 15600382
[TBL] [Abstract][Full Text] [Related]
51. The effects of antipsychotic therapy on serum lipids: a comprehensive review.
Meyer JM; Koro CE
Schizophr Res; 2004 Sep; 70(1):1-17. PubMed ID: 15246458
[TBL] [Abstract][Full Text] [Related]
52. Atypical antipsychotics for the treatment of delirious elders.
Ozbolt LB; Paniagua MA; Kaiser RM
J Am Med Dir Assoc; 2008 Jan; 9(1):18-28. PubMed ID: 18187109
[TBL] [Abstract][Full Text] [Related]
53.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
